SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARONI, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.031
EU - Europa 923
AS - Asia 497
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.020
CN - Cina 285
IT - Italia 266
DE - Germania 162
UA - Ucraina 154
GB - Regno Unito 98
TR - Turchia 96
PL - Polonia 63
SG - Singapore 60
SE - Svezia 56
FI - Finlandia 33
BE - Belgio 27
CZ - Repubblica Ceca 18
NL - Olanda 16
HK - Hong Kong 15
ID - Indonesia 14
VN - Vietnam 14
AU - Australia 9
CA - Canada 9
RU - Federazione Russa 9
PE - Perù 6
RO - Romania 6
ES - Italia 4
FR - Francia 4
JP - Giappone 4
IR - Iran 3
EU - Europa 2
GE - Georgia 2
IE - Irlanda 2
IN - India 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
DK - Danimarca 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
MK - Macedonia 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.470
Salva come PNG Salva come JPEG
Città #
Fairfield 383
Woodbridge 361
Chandler 274
Houston 206
Ann Arbor 190
Ashburn 178
Jacksonville 168
Seattle 162
Wilmington 150
Ferrara 141
Cambridge 123
Boardman 74
Izmir 66
Warsaw 62
Nanjing 58
Princeton 56
Beijing 55
New York 46
Milan 38
Dearborn 37
Shanghai 33
Bremen 32
Singapore 32
San Diego 31
Falls Church 23
Brussels 22
Nanchang 22
Shenyang 22
Munich 18
Brno 16
Redwood City 16
Hebei 14
Hong Kong 14
Jakarta 14
Norwalk 14
Dong Ket 13
Jiaxing 12
Guangzhou 11
Mcallen 11
Florence 9
San Mateo 9
Tianjin 9
Verona 9
Los Angeles 8
Montréal 8
Auburn Hills 7
Des Moines 7
London 7
Zhengzhou 7
Abdullah 6
Augusta 6
Changsha 6
Jinan 5
Kunming 5
Monmouth Junction 5
Mountain View 5
Bologna 4
Leawood 4
Lima 4
Louvain 4
Rome 4
Washington 4
Castellarano 3
Cento 3
Chicago 3
Düsseldorf 3
Fuzhou 3
Haikou 3
Helsinki 3
Hounslow 3
Indiana 3
Lleida 3
Lusia 3
Palermo 3
Reading 3
Redmond 3
Taizhou 3
Tokyo 3
Wuhan 3
Albignasego 2
Ariano nel Polesine 2
Dronten 2
Hangzhou 2
Hefei 2
Imola 2
Kilburn 2
Lockport 2
Marienheide 2
Melbourne 2
Meppel 2
Minerbio 2
Olomouc 2
Orange 2
Pavia 2
Pucallpa 2
Quzhou 2
Russi 2
Taiyuan 2
Amsterdam 1
Andover 1
Totale 3.431
Salva come PNG Salva come JPEG
Nome #
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 154
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 148
Hemostasis biomarkers in multiple sclerosis 144
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 139
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 134
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 130
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 127
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 122
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 119
Plasma levels of soluble NCAM in multiple sclerosis 118
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 115
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 115
Membrane binding and anticoagulant properties of protein S natural variants 111
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 106
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 105
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 105
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 100
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 98
null 94
null 93
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 91
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 90
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 90
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 89
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 89
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 86
null 84
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 83
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 83
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 76
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 75
null 73
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 73
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 72
THE NATURAL ARG386CYS MUTATION IN THE COAGULATION FACTOR X, AS A TOOL TO INVESTIGATE DIFFERENT FX-REQUIREMENTS IN INITIATION AND PROPAGATION PHASES. 69
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 69
The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII 64
Natural mutations in the EGF4 domain of protein S produce extended conformational changes and alter phospholipid and C4bBP interactions 60
Molecular characterization of factor X deficiency associated with borderline plasma factor X level 57
null 56
Non-conventional therapeutic strategies for inherited disorders of hemostasis 55
NATURAL MUTATIONS IN THE EGF4 DOMAIN OF PROTEIN S PRODUCE EXTENDED CONFORMATIONAL CHANGES AND ALTER PHOSPHOLIPID AND C4BBP INTERACTIONS 53
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 53
null 45
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 45
Hemostasis gene expression of the internal jugular and saphenous veins 42
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 40
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 39
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 36
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis (P3.368) 35
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 34
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 28
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 27
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 22
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 21
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 20
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 19
Coagulation factor VII variants resistant to inhibitory antibodies. 15
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 14
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 13
Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†) 12
Coagulation factor VII variants resistant to inhibitory antibodies 11
Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping 10
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 9
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 4
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions. 1
Totale 4.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020914 159 41 24 112 58 122 90 95 69 78 41 25
2020/2021820 47 42 27 97 25 58 81 80 50 145 123 45
2021/2022636 84 70 22 28 24 29 26 35 18 49 44 207
2022/2023634 60 64 23 87 92 88 46 50 67 8 37 12
2023/2024436 27 33 15 10 32 64 22 48 12 16 10 147
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 4.609